Tell the FDA your thoughts about CBD- before September 13, 2017
The Food and Drug Administration (FDA) has announced that it is taking comments on cannabidiol (CBD) and several other substances regarding their “abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes.” Comments will be accepted until September 13.
You may access the official FDA site by clicking HERE. If you have something to say about CBD now is the time.
I counsel clients in the hemp-based CBD industry on a daily basis. I’ve found that the biggest emerging obstacle to continued development of this sector is the FDA.
From the official site: “The Food and Drug Administration (FDA) is requesting interested persons to submit comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of 17 drug substances. These comments will be considered in preparing a response from the United States to the World Health Organization (WHO) regarding the abuse liability and diversion of these drugs. WHO will use this information to consider whether to recommend that certain international restrictions be placed on these drugs. This notice requesting comments is required by the Controlled Substances Act (the CSA).”